Bessemer Group’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.02M Sell
481,342
-1,595
-0.3% -$17.8K 0.01% 573
2026
Q1
$5.75M Buy
482,937
+156,095
+48% +$1.6M 0.01% 442
2025
Q4
$3.25M Buy
326,842
+326,383
+71,107% +$3.12M 0.01% 606
2025
Q3
$4K Buy
459
+319
+228% +$2.95K ﹤0.01% 2168
2025
Q2
$1K Hold
140
﹤0.01% 2260
2025
Q1
$2K Sell
140
-10
-7% -$101 ﹤0.01% 2196
2024
Q4
$1K Hold
150
﹤0.01% 2293
2024
Q3
$2K Sell
150
-119
-44% -$1.26K ﹤0.01% 2150
2024
Q2
$3K Sell
269
-1,125
-81% -$11.4K ﹤0.01% 1803
2024
Q1
$16K Hold
1,394
﹤0.01% 1470
2023
Q4
$10K Sell
1,394
-124
-8% -$978 ﹤0.01% 1590
2023
Q3
$13K Sell
1,518
-949
-38% -$11.4K ﹤0.01% 1530
2023
Q2
$30K Buy
2,467
+124
+5% +$1.38K ﹤0.01% 1453
2023
Q1
$29K Sell
2,343
-5,998
-72% -$110K ﹤0.01% 1322
2022
Q4
$160K Buy
+8,341
New +$176K ﹤0.01% 939

Other funds holding AHCO

Bessemer Group's AHCO Position: Q2 2026 in Review

Bessemer Group reduced its AdaptHealth (AHCO) stake by 0.33% in Q2 2026, selling an estimated $17.8K and leaving 481,342 shares worth $5.02M. The position accounts for 0.01% of the portfolio, ranked #573.

Bessemer Group first reported a position in AHCO in Q4 2022 and has held it in 15 quarters since. The position peaked at $5.75M in Q1 2026. 239 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • Bessemer Group held 481,342 shares of AdaptHealth worth $5.02M as of Q2 2026.
  • Bessemer Group sold 1,595 AdaptHealth shares in Q2 2026, an estimated $17.8K.
  • AdaptHealth made up 0.01% of Bessemer Group's portfolio in Q2 2026, its #573 holding.
  • Bessemer Group first reported a position in AdaptHealth in Q4 2022 and has held it in 15 quarters since.
  • Bessemer Group's AdaptHealth position peaked at $5.75M in Q1 2026.
  • 239 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.